Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review.
about
Early life programming as a target for prevention of child and adolescent mental disordersAntidepressants for depression during pregnancyPharmacotherapy of obsessive-compulsive disorder during pregnancy: a clinical approachA review of environmental contributions to childhood motor skillsCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersPerinatal depression: an update and overviewAntidepressant use in pregnancy: a critical review focused on risks and controversiesPrenatal SSRI use and offspring with autism spectrum disorder or developmental delay.Sensory Processing in Rhesus Monkeys: Developmental Continuity, Prenatal Treatment, and Genetic InfluencesPreschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function.Pharmacological treatment of unipolar depression during pregnancy and breast-feeding--a clinical overview.Effects of neonatal fluvoxamine administration on the physical development and activity of the serotoninergic system in white rats.Behavioral and developmental changes in rats with prenatal exposure of mirtazapine.Neurodevelopmental outcome for offspring of women treated for antenatal depression: a systematic reviewDevelopmental exposure to fluoxetine modulates the serotonin system in hypothalamus.Early-life exposure to the SSRI paroxetine exacerbates depression-like behavior in anxiety/depression-prone rats.Early neurological outcome of young infants exposed to selective serotonin reuptake inhibitors during pregnancy: results from the observational SMOK study.Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial.Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia.Genetic and pharmacological manipulations of the serotonergic system in early life: neurodevelopmental underpinnings of autism-related behavior.Of rodents and humans: A comparative review of the neurobehavioral effects of early life SSRI exposure in preclinical and clinical research.Lack of serotonin reuptake during brain development alters rostral raphe-prefrontal network formation.Effects of maternal psychotropic drug dosage on birth outcomes.Serotonin-related pathways and developmental plasticity: relevance for psychiatric disorders.When the bough breaks: rethinking treatment strategies for perinatal depression.Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence.A pharmacological approach to panic disorder during pregnancy.Use of psychotropic drugs during pregnancy and breast-feeding.Placental and fetal effects of antenatal exposure to antidepressants or untreated maternal depression.Use of Antidepressants During Pregnancy?: What to Consider when Weighing Treatment with Antidepressants Against Untreated Depression.Child developmental outcomes in preschool children following antidepressant exposure in pregnancy.Developmental outcomes of children exposed to antidepressants in pregnancy.Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study.Managing depression during pregnancy.Patterns and predictors of treatment outcome for antenatal major depression.Infant health and neurodevelopmental outcomes following prenatal exposure to duloxetine.Risk of impaired cognition after prenatal exposure to psychotropic drugs.A systematic review of maternal antidepressant use in pregnancy and short- and long-term offspring's outcomes.Neurodevelopmental Effects of Serotonin on the Brainstem Respiratory Network.Pharmacotherapy of mood disorders and psychosis in pre- and post-natal women.
P2860
Q21245282-D544028D-552F-4DEC-97ED-D3EB22E6CB75Q24200798-D7FE2573-6082-4D9B-A98E-9CF4F0737651Q26774013-875849D3-5752-4D85-9244-54DCCC492658Q26830011-FF3E838E-427B-4717-99CF-FCEB5DEAB716Q27009995-DAAB0DD3-7469-418C-9117-6028FC35DDB2Q27024923-F24C0DF4-060C-401E-B55E-ADB58BD0CF6CQ28281407-4E5152FD-495F-4353-9883-CC462172610FQ33551798-C597F15F-471B-4DED-B8B0-C02CF5FADBEDQ33655627-0DD777DC-9C96-4185-B5C2-5471B26D9FABQ33907544-C89E7589-0706-451D-884D-2C12174B5387Q34250131-77920AA1-88F8-44AF-9D4C-54EAFF254FE6Q34394292-6B6E2A22-BD97-4893-9F5A-7F0B0026B6E9Q34409959-3EB5BF9F-F7A8-4721-8AB6-6E8FC4814A13Q34544981-CB91553D-A07B-421A-A371-B61E3EE18C55Q34576006-0937B8D2-10F3-4F50-AEA8-0D3F034D0871Q34714284-17C432EF-A28D-44CB-AA33-5E5E22E7D9D7Q34778571-73124288-315D-4AEC-9D96-A7741A044793Q35963421-F643A12F-0AF1-461C-AB92-957B6531B6FFQ36648778-4A9697E1-E1AD-4BA1-AE5B-64633BABE8F9Q36921232-E905085C-F580-4288-A3A7-ECE3A761E025Q37058701-5C4B9CD2-E8EE-4FFD-95C2-352ECD1B791CQ37214031-54C57B38-50FB-4549-8A30-DFAB1A09AFAAQ37397151-0734E73B-8565-44FE-A41D-1562F213EF1FQ37699993-A43E96B7-19C8-43F6-937F-5A0E3501439CQ38089040-C92D4690-828E-40D1-8146-9043E7B70B7AQ38305749-DC52E0B9-4983-4455-AF61-4795BAF16D8EQ38516009-2BB0384A-C405-493C-A200-B79F632B8943Q38582061-7D0BFF1F-D863-41CF-9EC5-43C5C38A37CFQ38845135-875E9E74-EB16-4199-820B-5460BFC88988Q38909371-C91D8CDC-CEEC-4B87-9E95-A33FE4F430F0Q39037107-5E3BFF73-41AB-4384-B1D9-ED5F7AAE3465Q39783846-94FDD9FC-DCAA-4598-A752-1900C116D3D9Q40535809-5B1FCFC1-4CC6-4247-8F8B-BCF1E4149E82Q43451478-3B4C005F-2FD4-41DD-8D7B-330996F101CFQ45327750-F3441777-C1C1-48DE-96C0-F0B0400F01F4Q45949600-8AB3EBFE-1C79-4D5A-904C-C6165D57D68FQ47360060-92E25D14-0164-4C3B-AA32-BD4EA66DEC96Q47598536-3E83F5A4-650B-44D2-8E22-2F224DFFFBABQ47698440-A3CD9684-A908-49DC-8DF9-2A87CE105A03Q47743073-A2D4D2F0-0B81-462D-8EA4-DDE38A561435
P2860
Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prenatal exposure to antidepre ...... outcomes: a systematic review.
@en
Prenatal exposure to antidepre ...... outcomes: a systematic review.
@nl
type
label
Prenatal exposure to antidepre ...... outcomes: a systematic review.
@en
Prenatal exposure to antidepre ...... outcomes: a systematic review.
@nl
prefLabel
Prenatal exposure to antidepre ...... outcomes: a systematic review.
@en
Prenatal exposure to antidepre ...... outcomes: a systematic review.
@nl
P1476
Prenatal exposure to antidepre ...... outcomes: a systematic review.
@en
P2093
Megan Galbally
P356
10.1016/J.JAD.2010.02.125
P577
2010-03-19T00:00:00Z